[144] Nova Ltd. SEC Filing

Rhea-AI Filing Summary

Nova Ltd Director Simon Zehava has filed Form 144 indicating a proposed sale of 720 ordinary shares with an aggregate market value of $183,852. The sale is planned to execute on June 26, 2025 through Oppenheimer & Co. Inc. on the Nasdaq exchange.

The shares were originally acquired on June 17, 2019, as Restricted Stock Units from the issuer. The filing reveals this sale is being conducted under a 10b5-1 trading plan adopted on December 2, 2024.

Recent trading activity shows Zehava previously sold 135 ordinary shares on June 24, 2025, for gross proceeds of $32,400. The company currently has 29,278,401 shares outstanding.

This planned transaction represents a relatively small portion of Nova's total outstanding shares and is being executed through a pre-planned trading arrangement, suggesting a routine insider sale rather than a significant strategic divestment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001960000
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NOVA LTD.
SEC File Number	000-30668
Address of Issuer	5 DAVID FIKES STREET REHOVOT ISRAEL 7610201
Phone	972-73-229-5600
Name of Person for Whose Account the Securities are To Be Sold	Simon Zehava
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	720	183852.00	29278401	06/26/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/17/2019	Restricted Stock Units	Issuer			2220	06/17/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Simon Zehava 5 DAVID FIKES STREET REHOVOT L3 7610201	Ordinary	06/24/2025	135	32400.00

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 12/02/2024
Date of Notice	06/26/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/02/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Simon Zehava
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many NVMI shares is Director Simon Zehava planning to sell according to the Form 144 filed on June 28, 2025?

According to the Form 144 filing, Director Simon Zehava plans to sell 720 ordinary shares of Nova Ltd. (NVMI) through broker Oppenheimer & Co. Inc., with an aggregate market value of $183,852.00.

When did NVMI Director Simon Zehava originally acquire the shares being sold?

Director Simon Zehava acquired the shares on June 17, 2019 through Restricted Stock Units (RSUs) granted by the issuer. The original acquisition was for 2,220 shares.

What is the 10b5-1 trading plan date for NVMI Director Simon Zehava's share sale?

Simon Zehava adopted the 10b5-1 trading plan on December 2, 2024, with the planned sale execution date of June 26, 2025.

Has NVMI Director Simon Zehava sold any other shares in the past 3 months?

Yes, according to the filing, Simon Zehava sold 135 ordinary shares on June 24, 2025, with gross proceeds of $32,400.00.

What is the current total number of outstanding NVMI shares as reported in the Form 144?

According to the Form 144 filing, Nova Ltd. (NVMI) has 29,278,401 shares outstanding.